MESA LABORATORIES INC /CO/ director Tripeny R Tony received 1,774 derivative securities on 2026-09-09. The award represents about 100.0% of Tripeny R Tony’s resulting derivative-securities holding, giving investors a clear view of the entire position created by the disclosed transaction.
Key Highlights
- Tripeny R Tony’s resulting holding stood at 1,774 derivative securities.
- The transaction was classified under transaction code A, indicating an award or grant.
- The award accounted for about 100.0% of Tripeny R Tony’s resulting derivative-securities holding.
MESA LABORATORIES INC /CO/ director Tripeny R Tony received 1,774 derivative securities in an award dated 9 September 2026.
1,774 Derivative Securities Awarded
Tripeny R Tony held 1,774 derivative securities after the transaction. The awarded securities and the resulting derivative-securities holding were each reported at 1,774. The transaction date was 9 September 2026. The transaction represented about 100.0% of Tripeny R Tony’s resulting derivative-securities holding.
FAQs
Q: What did Tripeny R Tony receive from MESA LABORATORIES?
A: Tripeny R Tony received 1,774 derivative securities from MESA LABORATORIES in an award dated 9 September 2026. The resulting derivative-securities holding was also 1,774.
Q: What does the MESA LABORATORIES insider transaction mean?
A: The transaction was an award of 1,774 derivative securities to Tripeny R Tony, a director of MESA LABORATORIES INC /CO/. It represented about 100.0% of his resulting derivative-securities holding.
Q: How large was Tripeny R Tony’s resulting derivative holding?
A: Tripeny R Tony’s resulting holding consisted of 1,774 derivative securities after the award. The transaction accounted for about 100.0% of that resulting holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.